Quantcast
Last updated on April 18, 2014 at 9:56 EDT

Latest Artificial pancreas Stories

2013-09-27 16:23:48

Medtronic Product 'a First Step Toward an Artificial Pancreas' WASHINGTON, Sept. 27, 2013 /PRNewswire-USNewswire/ -- JDRF, the leading global organization funding type 1 diabetes (T1D) research, today applauded the U.S. Food and Drug Administration (FDA) for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose levels fall below a predetermined threshold. This morning, Medtronic announced FDA...

2013-09-24 23:23:33

Reportbuyer.com just published a new market research report: Global Blood Glucose Monitoring Devices Industry London (PRWEB) September 24, 2013 This report analyzes the worldwide markets for Blood Glucose Monitoring Devices in US$ Million by the following Product Segments: Blood Glucose Strips, Blood Glucose Meters, and Lancets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and...

2013-09-24 12:28:48

NEW YORK and Santa Barbara, Calif., Sept. 24, 2013 /PRNewswire-USNewswire/ -- JDRF, Sansum Diabetes Research Institute, and the College of Engineering at University of California, Santa Barbara (UCSB) are pleased to announce the first successful clinical research trial using the artificial pancreas in conjunction with ultra-rapid-acting inhaled insulin. This represents a groundbreaking potential advancement in the treatment of type 1 diabetes (T1D). It establishes that the disease can...

2013-09-06 12:21:58

BOSTON, Sept. 6, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest Type 1 Diabetes (T1DM) competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) Topics include: -- Save the cells: immune therapies for T1DM -- Beta-cell regeneration strategies -- Pancreatic replacement via...

2013-07-10 08:26:25

Provides match for $10.1M CIRM Strategic Partnership Award SAN DIEGO, July 10, 2013 /PRNewswire/ -- ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell-derived cell therapy, announced today that it completed a private equity financing transaction, providing the Company $10.6 million through the sale of Series C-1 Preferred Stock, together with warrants to purchase stock. The...

Insulin Pump Nears Approval In The US
2013-06-23 03:30:23

redOrbit Staff & Wire Reports - Your Universe Online An artificial pancreas is one step closer to receiving approval for sale in the US after a clinical trial showed the device, which can read a person’s blood sugar levels and supply insulin as needed, is safe. The MiniMed Integrated System, which is manufactured by Minneapolis-based Medtronic, is for use by type 1 diabetics. It features an insulin pump designed to halt the release of the hormone if a patient’s blood sugar...

2013-06-20 16:27:50

-- Xeris Pharmaceuticals, Inc., and LATITUDE Pharmaceuticals, Inc., will develop two different formulations of soluble glucagon for use in infusion pumps, and better determine their impact in regulating blood-glucose levels in people with type 1 diabetes-- NEW YORK, June 20, 2013 /PRNewswire-USNewswire/ -- JDRF announced today partnerships with both Xeris Pharmaceuticals, Inc., and LATITUDE Pharmaceuticals, Inc. (LPI), to support the development soluble glucagon formulations--an...

2013-06-19 23:19:28

In a new video Health News Wires discusses the dangers of insulin resistance and exactly how someone can increase insulin sensitivity through proper diet and herbal supplements. (PRWEB) June 19, 2013 The website HealthNewsWires.com has recently published an informative article and video describing insulin resistance, its harmful effects and tips to manage and prevent the condition. In a new article and video from HealthNewsWires.com, the author defines insulin resistance as a condition that...

2013-06-18 08:31:24

Combination of BD's proprietary technologies represents critical step toward artificial pancreas FRANKLIN LAKES, N.J. and NEW YORK, June 18, 2013 /PRNewswire/ -- JDRF and BD (Becton, Dickinson and Company) (NYSE:BDX) are accelerating the development of new products that combine BD's proprietary insulin infusion and glucose sensing technologies through a new collaboration announced today. This new, three-year commitment is an extension of existing JDRF-BD collaborations focused on...

Stem Cells And New Drug Could Reverse Type 1 Diabetes
2013-05-30 04:49:45

redOrbit Staff & Wire Reports - Your Universe Online Damage caused to insulin-producing cells by the immune systems of type 1 diabetes patients could be more damaging than previously believed, but a University of Missouri scientist believes that their new discovery could lead to the development of a potential cure for the condition. Individuals suffering from type 1 diabetes rely upon their daily insulin injections in order to survive, and without those shots their body´s...